ResearcherHanyang UniversityActive in the last 2 years
Chae‐Ok Yun
Matched on ORCID iD 0000-0002-9466-4531; OpenAlex author ID A5056411116. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 0, last author 5)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 8
2017: 2 papers · 2018: 1 paper · 2019: 1 paper · 2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper · 2024: none · 2025: none · 2026: 1 paper
Papers 7
- Oncolytic adenovirus in combination with PD-L1-targeted radioimmunotherapy exerts synergistic antitumor effect against pancreatic cancer. Last author DOI 10.1136/jitc-2025-014508↗
- Oncolytic adenovirus as pancreatic cancer-targeted therapy: Where do we go from here? Last author DOI 10.1016/j.canlet.2023.216456↗
- Erratum: Oh, E., et al. Cryopreserved Human Natural Killer Cells Exhibit Potent Antitumor Efficacy against Orthotopic Pancreatic Cancer through Efficient Tumor… Last author DOI 10.3390/cancers12113255↗
- Cryopreserved Human Natural Killer Cells Exhibit Potent Antitumor Efficacy against Orthotopic Pancreatic Cancer through Efficient Tumor-Homing and Cytolytic Ab… Last author DOI 10.3390/cancers11070966↗
- Potent antitumor effect of tumor microenvironment-targeted oncolytic adenovirus against desmoplastic pancreatic cancer. Last author DOI 10.1002/ijc.31060↗
- Oncolytic adenovirus expressing relaxin (YDC002) enhances therapeutic efficacy of gemcitabine against pancreatic cancer. Co-author DOI 10.1016/j.canlet.2017.03.009↗
- Corrigendum to "Oncolytic adenovirus expressing relaxin (YDC002) enhances therapeutic efficacy of gemcitabine against pancreatic cancer" [Cancer Lett. 396 (201… Co-author DOI 10.1016/j.canlet.2017.06.019↗
Closest collaborators
The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Arum R. Yoon · 3 shared papers, 2018–2026 · strength 0.58
- Paper Oncolytic adenovirus in combination with PD-L1-targeted radioimmunotherapy exerts synergistic antitumor effect against … DOI 10.1136/jitc-2025-014508↗
- Paper Oncolytic adenovirus as pancreatic cancer-targeted therapy: Where do we go from here? DOI 10.1016/j.canlet.2023.216456↗
- Paper Potent antitumor effect of tumor microenvironment-targeted oncolytic adenovirus against desmoplastic pancreatic cancer. DOI 10.1002/ijc.31060↗
- Jin Su Kim · 1 shared paper, 2026 · strength 0.26
- Eonju Oh · 2 shared papers, 2019–2020 · strength 0.20
- Paper Erratum: Oh, E., et al. Cryopreserved Human Natural Killer Cells Exhibit Potent Antitumor Efficacy against Orthotopic P… DOI 10.3390/cancers12113255↗
- Paper Cryopreserved Human Natural Killer Cells Exhibit Potent Antitumor Efficacy against Orthotopic Pancreatic Cancer through… DOI 10.3390/cancers11070966↗
- Mi Kwon Son · 2 shared papers, 2017 · strength 0.14
- Paper Oncolytic adenovirus expressing relaxin (YDC002) enhances therapeutic efficacy of gemcitabine against pancreatic cancer. DOI 10.1016/j.canlet.2017.03.009↗
- Paper Corrigendum to "Oncolytic adenovirus expressing relaxin (YDC002) enhances therapeutic efficacy of gemcitabine against p… DOI 10.1016/j.canlet.2017.06.019↗
- Hong Hua Yan · 2 shared papers, 2017 · strength 0.14
- Paper Oncolytic adenovirus expressing relaxin (YDC002) enhances therapeutic efficacy of gemcitabine against pancreatic cancer. DOI 10.1016/j.canlet.2017.03.009↗
- Paper Corrigendum to "Oncolytic adenovirus expressing relaxin (YDC002) enhances therapeutic efficacy of gemcitabine against p… DOI 10.1016/j.canlet.2017.06.019↗
- Kyung Hee Jung · 2 shared papers, 2017 · strength 0.14
- Paper Oncolytic adenovirus expressing relaxin (YDC002) enhances therapeutic efficacy of gemcitabine against pancreatic cancer. DOI 10.1016/j.canlet.2017.03.009↗
- Paper Corrigendum to "Oncolytic adenovirus expressing relaxin (YDC002) enhances therapeutic efficacy of gemcitabine against p… DOI 10.1016/j.canlet.2017.06.019↗
- Soon‐Sun Hong · 2 shared papers, 2017 · strength 0.14
- Paper Oncolytic adenovirus expressing relaxin (YDC002) enhances therapeutic efficacy of gemcitabine against pancreatic cancer. DOI 10.1016/j.canlet.2017.03.009↗
- Paper Corrigendum to "Oncolytic adenovirus expressing relaxin (YDC002) enhances therapeutic efficacy of gemcitabine against p… DOI 10.1016/j.canlet.2017.06.019↗
- Yan Li · 1 shared paper, 2018 · strength 0.11
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.